Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare

>>

Global Recombinant Protein Market


Global Recombinant Protein Market By Product Type [Hormones, Growth Factor, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators and others],By Application [Drug Discovery & Development, Biopharmaceutical Production, Basic Research and Others], By End User[Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations and Others]: Market Research Report 2021 Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast -2026

Report code: SDMRHE1566531 | Industry: Healthcare | Published On: 1/1/2021


Global Recombinant Protein Market 2020 By Product Type [Hormones, Growth Factor, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators and others],By Application [Drug Discovery & Development, Biopharmaceutical Production, Basic Research and Others], By End User[Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations and Others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Recombinant Protein Market is valued at 414.3 USD Million in 2019 and expected to reach USD 631.1 Million by 2026 with the CAGR of 6.20% over the forecast period.

Scope of the report
This report analyses the global market for Recombinant Protein. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.


Key Players

BPS Bioscience, Inc., Crown Bioscience Inc., Eli Lilly and Company, GenScript, GlaxoSmithKline plc, Merck & Co., Inc., Novoprotein, PeproTech, Inc., Prospec-Tany Technogene Ltd., Proteintech Groupand others
Above mentioned companies were scrutinized to assess competitive landscape of global Recombinant Protein market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.




Review period: (2016-2026)



Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Million
This Recombinant Protein market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.



Regions


• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa





Market Segmentation




• Product Type
o Hormones
o Growth Factor
o Cytokines
o Plasma Protein Factor
o Recombinant Metabolic Enzymes
o Immune Checkpoint Regulators
• Application
o Drug Discovery & Development
o Biopharmaceutical Production
o Basic Research
o Others
• End User
o Biopharmaceutical Companies
o Academic & Research Institutes
o Contract Research Organizations
o Others






Report Coverage





• An overview of the global Recombinant Protein market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Recombinant Protein market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Recombinant Protein market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Recombinant Protein Market Report
• What is the impact of COVID 19 epidemic on the global Recombinant Protein market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Recombinant Protein market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Recombinant Protein market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?

Table  of  Contents
1.  Introduction
1.1.  Report  Description
1.2.  Market  Segmentation
1.3.  Research  Methodology
1.4.  List  of  Abbreviations
2.  Executive  Summary
3.  Market  Overview
3.1.  Market  Definition  
3.2.  Market  Scope
3.3.  Market  Drivers
3.4.  Market  Restraints
3.5.  Market  Opportunities  and  Trends
3.6.  Porter’s  five  force  analysis
3.7.  SWOT  Analysis
3.8.  PEST  Analysis
3.9.  Patent  Analysis
3.10.  Impact  of  COVID  19  on  Global  Recombinant  Protein  Market
4.  Recombinant  Protein  Market,  By  Product  Type,  Market  Size  and  Forecast  2016  -2026  (USD  Billion)
4.1.  Global  Recombinant  Protein  Market  By  Product  Type,  2016  -2026  (USD  Billion)
4.1.1.  Global  Recombinant  Protein  Market  By  Hormones
4.1.2.  Global  Recombinant  Protein  Market  By  Growth  Factor
4.1.3.  Global  Recombinant  Protein  Market  By  Cytokines  
4.1.4.  Global  Recombinant  Protein  Market  By  Plasma  Protein  Factor  
4.1.5.  Global  Recombinant  Protein  Market  By  Recombinant  Metabolic  Enzymes  
4.1.6.  Global  Recombinant  Protein  Market  By  Immune  Checkpoint  Regulators  
4.2.  Global  Recombinant  Protein  Market  By  Product  Type  Share,  2016  -2026  (%)
5.  Recombinant  Protein  Market,  By  End  User,  Market  Size  and  Forecast  2016  -2026  (USD  Billion)
5.1.  Global  Recombinant  Protein  Market  By  End  User,  2016  -2026  (USD  Billion)
5.1.1.  Global  Recombinant  Protein  Market  By  Biopharmaceutical  Companies
5.1.2.  Global  Recombinant  Protein  Market  By  Academic  &  Research  Institutes
5.1.3.  Global  Recombinant  Protein  Market  By  Contract  Research  Organizations
5.1.4.  Global  Recombinant  Protein  Market  By  Others  
5.2.  Global  Recombinant  Protein  Market  By  End  User  Share,  2016  -2026  (%)
6.  Recombinant  Protein  Market,  By  Application,  Market  Size  and  Forecast  2016  -2026  (USD  Billion)
6.1.  Global  Recombinant  Protein  Market  By  Application,  2016  -2026  (USD  Billion)
6.1.1.  Global  Recombinant  Protein  Market  By  Drug  Discovery  &  Development
6.1.2.  Global  Recombinant  Protein  Market  By  Biopharmaceutical  Production
6.1.3.  Global  Recombinant  Protein  Market  By  Basic  Research
6.1.4.  Global  Recombinant  Protein  Market  By  Others  
6.2.  Global  Recombinant  Protein  Market  By  Application  Share,  2016  -2026  (%)
7.  Recombinant  Protein  Market,  By  Region  Market  Size  and  Forecast  2016  -2026
7.1.  NORTH  AMERICA
7.1.1.  Key  Findings
7.1.2.  Impact  of  COVID  19
7.1.3.  Key  market  trends,  growth  factors  and  opportunities
7.1.4.  North  America  Recombinant  Protein  Market  by  Country  2016  -2026  (USD  Billion)
7.1.5.  North  America  Recombinant  Protein  Market  By  Product  Type  2016  -2026  (USD  Billion)
7.1.6.  North  America  Recombinant  Protein  Market  By  Application  2016  -2026  (USD  Billion)
7.1.7.  North  America  Recombinant  Protein  Market  By  End  User  2016  -2026  (USD  Billion)
7.2.  EUROPE
7.2.1.  Key  Findings
7.2.2.  Impact  of  COVID  19
7.2.3.  Key  market  trends,  growth  factors  and  opportunities
7.2.4.  Europe  Recombinant  Protein  Market  by  Country  2016  -2026  (USD  Billion)
7.2.5.  Europe  Recombinant  Protein  Market  By  Product  Type  2016  -2026  (USD  Billion)
7.2.6.  Europe  Recombinant  Protein  Market  By  Application  2016  -2026  (USD  Billion)
7.2.7.  Europe  Recombinant  Protein  Market  By  End  User  2016  -2026  (USD  Billion)
7.3.  ASIA  PACIFIC
7.3.1.  Key  Findings
7.3.2.  Impact  of  COVID  19
7.3.3.  Key  market  trends,  growth  factors  and  opportunities
7.3.4.  Asia  Pacific  Recombinant  Protein  Market  by  Country  2016  -2026  (USD  Billion)
7.3.5.  Asia  Pacific  Recombinant  Protein  Market  By  Product  Type  2016  -2026  (USD  Billion)
7.3.6.  Asia  Pacific  Recombinant  Protein  Market  By  Application  2016  -2026  (USD  Billion)
7.3.7.  Asia  Pacific  Recombinant  Protein  Market  By  End  User  2016  -2026  (USD  Billion)
7.4.  LATIN  AMERICA
7.4.1.  Key  Findings
7.4.2.  Impact  of  COVID  19
7.4.3.  Key  market  trends,  growth  factors  and  opportunities
7.4.4.  Latin  America  Recombinant  Protein  Market  by  Country  2016  -2026  (USD  Billion)
7.4.5.  Latin  America  Recombinant  Protein  Market  By  Product  Type  2016  -2026  (USD  Billion)
7.4.6.  Latin  America  Recombinant  Protein  Market  By  Application  2016  -2026  (USD  Billion)
7.4.7.  Latin  America  Recombinant  Protein  Market  By  End  User  2016  -2026  (USD  Billion)
7.5.  MIDDLE  EAST  AND  AFRICA
7.5.1.  Key  Findings
7.5.2.  Impact  of  COVID  19
7.5.3.  Key  market  trends,  growth  factors  and  opportunities
7.5.4.  Middle  East  and  Africa  Recombinant  Protein  Market  by  Country  2016  -2026  (USD  Billion)
7.5.5.  Middle  East  and  Africa  Recombinant  Protein  Market  By  Product  Type  2016  -2026  (USD  Billion)
7.5.6.  Middle  East  and  Africa  Recombinant  Protein  Market  By  Application  2016  -2026  (USD  Billion)
7.5.7.  Middle  East  and  Africa  Recombinant  Protein  Market  By  End  User  2016  -2026  (USD  Billion)
8.  Competitive  Landscape  Analysis
8.1.  Global  Recombinant  Protein  Market  Company  Revenue,  (USD  Billion),  2016-2019
8.2.  Global  Recombinant  Protein  Market  Company  Share,  (%),  2016-2019
9.  Company  Profiles
9.1.  BPS  Bioscience,  Inc.
9.2.  Crown  Bioscience  Inc.
9.3.  Eli  Lilly  and  Company
9.4.  GenScript
9.5.  GlaxoSmithKline  plc
9.6.  Merck  &  Co.,  Inc.
9.7.  Novoprotein
9.8.  PeproTech,  Inc.
9.9.  Prospec-Tany  Technogene  Ltd.
9.10.  Proteintech  Group
9.11.  Others  

10.  Appendix
11.  List  of  Tables  
12.  List  of  Figures  



 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT